Table 3.
Treatments received in patients with HER2-positive BCP and HER2 non-BCP group.
| HER2-positive BCP (n = 51) | HER2 non-BCP (n = 51) | p | |
|---|---|---|---|
| Chemotherapy | |||
| Neoadjuvant | 36 (72) | 26 (51) | 0.03 |
| Adjuvant | 14 (27) | 25 (49) | 0.04 |
| Mammary surgery | |||
| Partial mastectomy | 17 (34) | 23 (45) | 0.25 |
| Total mastectomy | 29 (58) | 32 (63) | 0.63 |
| None | 5 (9.8) | 0 | 1 |
| Axillary surgery, n(%) | |||
| Sentinel lymph node (SLN) | 13 (26) | 13 (26) | 1 |
| Lymphadenectomy | 31 (62) | 43 (84) | 0.01 |
| None | 7 (13.7) | 0 | 1 |
| Postpartum radiotherapy | 43 (86) | 47 (92) | 0.32 |
| Antihormonal treatment | 34 (66.7) | 39 (76.5) | 0.27 |